FRIDAY, Nov. 21, 2025 (HealthDay News) — Pfizer’s mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported. The results, published Nov. 19 in The New England Journal of Medicine, suggest that mRNA technology may help improve protection in future flu seasons.Continue Reading
THURSDAY, Nov. 20, 2025 (HealthDay News) — New guidelines recommend doctors tackle Crohn’s disease head-on, calling for the use of cutting-edge drugs as early as possible to quell the autoimmune GI disorder as quickly as possible. The updated American Gastroenterological Association guidelines reject a “step-up” approach in which people getContinue Reading
TUESDAY, Nov. 18, 2025 (HealthDay News) — Pharmaceutical companies are using the citizens of lower-income countries as guinea pigs to test cutting-edge drugs headed mainly for the United States and other well-off nations, a new study says. Only a quarter of medicines tested in other countries wound up available toContinue Reading
MONDAY, Nov. 17, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) is tightening restrictions on a gene therapy used to treat Duchenne muscular dystrophy after two teenagers died from liver failure linked to the medication. The FDA decision limits the use of Elevidys, made by Sarepta Therapeutics,Continue Reading
MONDAY, Nov. 17, 2025 (HealthDay News) — Life imitates art, the saying goes, but does that extend to TV depictions of prescription drug misuse? The last season of the HBO hit series “The White Lotus” might have inadvertently increased interest in a powerful anti-anxiety medication, a new study says. InternetContinue Reading
The division lost about 1,000 staff this year amid turnover and morale concernsContinue Reading
MONDAY, Nov. 10, 2025 (Health News) — Millions of Americans who rely on medication for attention deficit hyperactivity disorder (ADHD) may be affected by a new drug recall. Sun Pharmaceutical Industries has issued a voluntary, nationwide recall for several lots of lisdexamfetamine dimesylate capsules, a generic version of an ADHDContinue Reading
THURSDAY, Nov. 6, 2025 (HealthDay News) — Tweens and teens who vape are becoming hopelessly hooked on nicotine, a new study warns. Daily nicotine vaping nearly doubled between 2020 and 2024 among U.S. middle and high school students who use e-cigarettes, researchers reported Nov. 3 in JAMA Network Open. TheContinue Reading
TUESDAY, Nov. 4, 2025 (HealthDay News) — Low-dose aspirin is no longer universally recommended to prevent heart health emergencies, but it might help people with type 2 diabetes, a new study says. People with type 2 diabetes who took low-dose aspirin were less likely to have a heart attack orContinue Reading
MONDAY, Nov. 3, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has recalled over half a million bottles of a widely prescribed blood pressure medication, prazosin hydrochloride, because of concerns about a potentially cancer-causing chemical. New Jersey-based Teva Pharmaceuticals and drug distributor Amerisource Health Services initiated theContinue Reading